Department of Molecular Epidemiology, German Institute of Human Nutrition, Arthur-Scheunert-Allee 114-116, 14558, Nuthetal, Germany.
Curr Diab Rep. 2013 Apr;13(2):279-88. doi: 10.1007/s11892-012-0362-8.
Polyunsaturated fatty acids are of particular interest in the nutritional therapy for diabetes, given their potential role in several pathophysiological processes related to cardiovascular disease. Both omega-3 and omega-6 fatty acids are beneficial for improving lipid profiles in healthy individuals and among type 2 diabetic patients: Supplementation with omega-3 fatty acids lowers triglycerides and VLDL-cholesterol. However, they might also increase LDL-cholesterol. Omega-3 fatty acids are, from the latest evidence, not related to mortality and cardiovascular disease. Similarly, glucose control and hypertension, as well as risk of microvascular complications, seem unaffected by omega-3 supplementation. Most studies involved mainly patients with type 2 diabetes, and future research needs to focus on the type 1 diabetic patient. Also, the role of omega-6 fatty acids remains largely unknown.
多不饱和脂肪酸在糖尿病的营养治疗中特别引人关注,因为它们在与心血管疾病相关的多种病理生理过程中具有潜在作用。ω-3 和 ω-6 脂肪酸都有益于改善健康个体和 2 型糖尿病患者的血脂谱:ω-3 脂肪酸补充剂可降低甘油三酯和 VLDL-胆固醇。然而,它们也可能增加 LDL-胆固醇。根据最新证据,ω-3 脂肪酸与死亡率和心血管疾病无关。同样,葡萄糖控制和高血压以及微血管并发症的风险似乎不受 ω-3 补充的影响。大多数研究主要涉及 2 型糖尿病患者,未来的研究需要集中在 1 型糖尿病患者上。此外,ω-6 脂肪酸的作用在很大程度上仍然未知。